Alcon

Alcon Cash Conversion Cycle

The Cash Conversion Cycle (CCC) of Alcon (ALC.SW) as of Sep 25, 2026 is 189.61. In the previous year, Cash Conversion Cycle (CCC) was 202.71 — a change of -6.47% (lower).

Cash Conversion Cycle

189.61

YoY

-6.47%

Last updated:

Cash Conversion Cycle (CCC) of Alcon is 2026 189.61 . Cash Conversion Cycle (CCC) of Alcon was 2025 202.71 . It decreases by -6.47% lower compared to the previous year.

The Alcon Cash Conversion Cycle history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Cash Conversion Cycle
Date
Cash Conversion Cycle
Jan 1, 2018
146.79 USD
Jan 1, 2019
146.92 USD
Jan 1, 2020
161.46 USD
Jan 1, 2021
180.94 USD
Jan 1, 2022
200.97 USD
Jan 1, 2023
215.14 USD
Jan 1, 2024
202.71 USD
Jan 1, 2025
189.61 USD
The Alcon Cash Conversion Cycle history
YEARCash Conversion CycleYoY
189.61-6.47%
202.71-5.78%
215.14+7.05%
200.97+11.07%
180.94+12.06%
161.46+9.90%
146.92+0.09%
146.79-4.14%
153.13+143.68%
62.84-7.43%
67.89—
Access this data via the Eulerpool API

Alcon Stock analysis

What does Alcon do? Alcon AG is a leading company in ophthalmology with more than 70 years of experience in this industry. The company was founded in 1945 by Robert Alexander and William Conner and has its headquarters in Geneva, Switzerland. Alcon AG has been part of the Novartis Group since 2019 and is a leader in the production of ophthalmic products. The business model of Alcon AG is based on the manufacturing and sale of ophthalmic products. The company offers medical products such as contact lenses, surgical instruments, eye drops, and intraocular lenses. Alcon AG specializes in the development of products that can be used for various eye diseases. The company provides a wide range of products that can be used by ophthalmologists and opticians. The various divisions of Alcon AG include eye care products, surgical products, and diagnostic products. Eye care products, such as contact lenses, offer consumers a safe and easy way to correct their vision. Surgical products include a wide range of instruments used in eye surgeries. Diagnostic products help identify eye diseases and support treatment. Alcon AG specializes in the development of products for the treatment of eye diseases. These include conditions such as cataracts, glaucoma, and age-related macular degeneration. The company offers various products that can be used for these conditions, such as eye drops to reduce elevated eye pressure in glaucoma. It has also developed a wide range of products for refractive correction, allowing people to improve their vision. Alcon AG works closely with leading ophthalmologists and opticians to optimize its product development. This close collaboration ensures that Alcon AG's products meet the needs of patients and provide them with high safety and effectiveness. With its innovative products and technologies, Alcon AG aims to improve the quality of life for patients and provide them with optimal care and treatment. Overall, Alcon AG is a leading company in ophthalmology, offering its customers a wide range of innovative and high-quality products. From diagnosis to care to surgical interventions, Alcon AG's product range covers all areas of ophthalmology. The company is known for its research and development and is constantly working towards advancing ophthalmology. Through its continuous innovation and customer orientation, Alcon AG has established a strong position in the healthcare industry and will continue to introduce new products and technologies in the future. Alcon is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Alcon stock

Cash Conversion Cycle (CCC) of Alcon is 189.61 in 2026.

Cash Conversion Cycle (CCC) of Alcon changed from 202.71 to 189.61, representing a -6.47% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Cash Conversion Cycle (CCC) Alcon since 2006 – with annual values, charts, and detailed analysis.

The Cash Conversion Cycle measures how long it takes to convert inventory investments into cash from sales. A shorter CCC indicates more efficient working capital management.

CCC = DSO + DIO - DPO

A 'good' varies by industry and company stage. On Eulerpool, you can compare Cash Conversion Cycle (CCC)'s Alcon with sector peers and the industry average to assess whether it is attractive.

To evaluate Cash Conversion Cycle (CCC)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Cash Conversion Cycle (CCC).

Access this data via the Eulerpool API

Profitability — Alcon

All Key Metrics — Alcon